$120,000 of ENTEGRIS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to implementation of the CHIPS and Science Act (Pub. L. 117-167); issues connected to potential reintroduction of H.R. 6207/S.3301 - the Chip Equipment Quality, Usefulness, and Integrity Protection (Chip EQUIP) Act of 2025. Issues related to implementation of the CHIPS and Science Act (Pub. L. 117-167); issues connected to potential reintroduction of H.R. 6207/S.3301 - the Chip Equipment Quality, Usefulness, and Integrity Protection (Chip EQUIP) Act of 2025. Issues related to implementation of the CHIPS and Science Act (Pub. L. 117-167). Issues related to Section 48D of the Internal Revenue Code and Section 107 of the Chips and Science Act; S. 1642 (Strengthening Essential Manufacturing and Industrial Investment Act); One Big Beautiful Bill Act. Issues related to export control policy relevant to the semiconductor supply chain ecosystem. Issues connected to administrative review of patent applications and dispute resolution."
You can find more data on corporate lobbying on Quiver Quantitative.
ENTG Congressional Stock Trading
Members of Congress have traded $ENTG stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ENTG stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 10/30, 08/04 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE APRIL MCCLAIN DELANEY sold up to $15,000 on 07/28.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ENTG Insider Trading Activity
ENTG insiders have traded $ENTG stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ENTG stock by insiders over the last 6 months:
- BERTRAND LOY (Executive Chair) has made 0 purchases and 3 sales selling 57,570 shares for an estimated $4,425,994.
- SUSAN G. RICE (SVP, Global Human Resources) sold 8,858 shares for an estimated $707,222
- CLINTON M. HARIS (SVP & President, APS Division) sold 3,627 shares for an estimated $326,430
- JOSEPH COLELLA (SVP and General Counsel) sold 3,577 shares for an estimated $316,242
- JAMES P LEDERER sold 2,008 shares for an estimated $186,422
- OLIVIER BLACHIER (SVP, Chief Strategy Officer) sold 488 shares for an estimated $37,785
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ENTG Hedge Fund Activity
We have seen 282 institutional investors add shares of ENTG stock to their portfolio, and 281 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 6,974,133 shares (+inf%) to their portfolio in Q3 2025, for an estimated $644,828,337
- D1 CAPITAL PARTNERS L.P. removed 3,019,633 shares (-72.4%) from their portfolio in Q3 2025, for an estimated $279,195,267
- BAILLIE GIFFORD & CO removed 2,058,007 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $190,283,327
- VAN ECK ASSOCIATES CORP added 2,053,869 shares (+1721.7%) to their portfolio in Q3 2025, for an estimated $189,900,727
- INVESCO LTD. added 2,050,473 shares (+183.5%) to their portfolio in Q3 2025, for an estimated $189,586,733
- HOLOCENE ADVISORS, LP removed 1,859,828 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $171,959,696
- FMR LLC added 1,857,388 shares (+1015.8%) to their portfolio in Q3 2025, for an estimated $171,734,094
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENTG Analyst Ratings
Wall Street analysts have issued reports on $ENTG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 01/09/2026
- Mizuho issued a "Outperform" rating on 10/03/2025
To track analyst ratings and price targets for ENTG, check out Quiver Quantitative's $ENTG forecast page.
ENTG Price Targets
Multiple analysts have issued price targets for $ENTG recently. We have seen 5 analysts offer price targets for $ENTG in the last 6 months, with a median target of $95.0.
Here are some recent targets:
- Aleksey Yefremov from Keybanc set a target price of $111.0 on 01/09/2026
- James Schneider from Goldman Sachs set a target price of $75.0 on 12/15/2025
- John Roberts from Mizuho set a target price of $96.0 on 11/20/2025
- Edward Yang from Oppenheimer set a target price of $95.0 on 09/04/2025
- Timothy Arcuri from UBS set a target price of $90.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
